Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Atopic Dermatitis”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00691145
What this trial is testing

Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Astellas Pharma Inc 350
Early research (Phase 1)Study completedNCT06686797
What this trial is testing

Learn How Different Amounts of the Study Medicine Called PF-08049820 Are Tolerated and Act in the Body in Healthy Adults

Who this might be right for
Healthy
Pfizer 71
Very early researchStudy completedNCT02343783
What this trial is testing

Evaluate Use of Induced Skin Blisters in Adult Participants With Atopic Dermatitis, Allergic Asthma and Atopic Healthy Participants

Who this might be right for
Dermatitis, AtopicAsthmaHealthy
Janssen Research & Development, LLC 46
Testing effectiveness (Phase 2)Study completedNCT06723405
What this trial is testing

Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)EczemaEczema Atopic Dermatitis
Evommune, Inc. 71
Very early researchStudy completedNCT04613037
What this trial is testing

Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Tel-Aviv Sourasky Medical Center 15
Large-scale testing (Phase 3)Study completedNCT00523952
What this trial is testing

Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients

Who this might be right for
Dermatitis, Atopic
Astellas Pharma Inc 303
Early research (Phase 1)Looking for participantsNCT07693738
What this trial is testing

A Phase I Study of SSGJ-716 in Healthy Adults and Participants With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
AD
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 96
Early research (Phase 1)Study completedNCT04544943
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Application of Topical BioLexa in Adult Healthy Subjects and Patients With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Hoth Therapeutics, Inc. 31
Large-scale testing (Phase 3)Not Yet RecruitingNCT07479615
What this trial is testing

Evaluate the Efficacy and Safety of MG-K10 in Participants Who Have Atopic Dermatitis

Who this might be right for
Atopic DermatitisAtopic Eczema
Shanghai Mabgeek Biotech.Co.Ltd 498
Not applicableNot Yet RecruitingNCT07276620
What this trial is testing

Treatment of Moderate-to-Severe Atopic Dermatitis With Ivarmacitinib in Adolescents and Adults

Who this might be right for
Atopic Dermatitis (AD)
Xiangya Hospital of Central South University 1,000
Large-scale testing (Phase 3)Study completedNCT02277743
What this trial is testing

Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Regeneron Pharmaceuticals 671
Not applicableWithdrawnNCT05545215
What this trial is testing

Prospective Real-World Clinical Investigation on Dexyane Med® in Adults With Chronic Hand Eczema

Who this might be right for
Chronic Hand Eczema
Pierre Fabre Medicament
Early research (Phase 1)Not Yet RecruitingNCT07042113
What this trial is testing

Two Different Formulations of 611 in Healthy Adult Subjects in China

Who this might be right for
Atopic Dermatitis
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 180
Not applicableStudy completedNCT01132079
What this trial is testing

Pimecrolimus and Epidermal Barrier Function

Who this might be right for
Atopic Dermatitis
University of Kiel 15
Post-approval studies (Phase 4)Study completedNCT00117377
What this trial is testing

Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Novartis 70
Large-scale testing (Phase 3)Study completedNCT06921759
What this trial is testing

Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Hand and Foot Dermatitis

Who this might be right for
Atopic Hand and Foot Dermatitis
Eli Lilly and Company 221
Large-scale testing (Phase 3)Study completedNCT02395133
What this trial is testing

Confirm the Efficacy and Safety of Different Dupilumab Dose Regimens in Adults With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Regeneron Pharmaceuticals 422
Testing effectiveness (Phase 2)Study completedNCT04800315
What this trial is testing

Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, AtopicEczema
Celgene 221
Not applicableLooking for participantsNCT06313333
What this trial is testing

National Register of Moderate and Severe Adult Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse 1,500
Testing effectiveness (Phase 2)Study completedNCT06891040
What this trial is testing

Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Jiangsu vcare pharmaceutical technology co., LTD 118
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation